GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Study Identifies HAT1 as Regulator of Monocyte Behavior in Post-Heart Attack Inflammation

by GOAI
Share To

A recent study has identified histone acetyltransferase 1 (HAT1) as a key regulator in the inflammatory response following a heart attack. Researchers have determined that HAT1 plays a significant role in influencing monocyte behavior, which is critical to understanding the molecular mechanisms behind cardiac inflammation after myocardial infarction. The findings stem from an interdisciplinary investigation led by Guo, Y., Xiong, J., and Li, Z.

The study highlights how HAT1 impacts the postinfarction inflammatory process, shedding light on its potential role in modulating immune responses during cardiac injury. Monocytes, a type of white blood cell involved in inflammation and tissue repair, appear to be directly affected by HAT1 activity. This research provides new insights into the biological pathways that drive inflammation after heart attacks and may inform future studies aimed at developing targeted therapies for managing postinfarction complications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top